Aardvark Therapeutics, Inc. Common Stock

General ticker "AARD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $146.0M (TTM average)

Aardvark Therapeutics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -11.4%.

Estimated limits based on current volatility of 11.8%: low 1.11$, high 1.40$

Factors to consider:

  • Total employees count: 40 (+81.8%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Limited operating history, Need additional capital, Regulatory and compliance, Product development failure, Intellectual property risks

Similar symbols

Short-term AARD quotes

Long-term AARD plot

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $7.42MM $22.79MM $62.73MM
Operating Income $-7.42MM $-22.79MM $-62.73MM
Non-Operating Income $0.21MM $2.20MM $5.13MM
R&D Expense $4.48MM $17.36MM $48.94MM
Income(Loss) $-7.21MM $-20.59MM $-57.59MM
Net Income(Loss)* $-7.21MM $-20.59MM $-57.59MM
Stockholders Equity $-34.80MM $-54.64MM $106.63MM
Assets $10.54MM $77.51MM $117.18MM
Operating Cash Flow $-5.82MM $-18.09MM $-54.17MM
Capital expenditure $0.00MM $0.11MM $0.10MM
Investing Cash Flow $0.00MM $-12.00MM $-49.67MM
Financing Cash Flow $0.00MM $81.99MM $89.25MM
Earnings Per Share** $-0.34 $-0.95 $-2.64

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.